COMPASS Pathways plc(CMPS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CMPS COMPASS Pathways plc

Pre-Mkt 11-02 04:25:58 EST

11.57

-0.62

-5.09%

盘前11.98

+0.41+3.54%

04:10 EST

High11.99	Low11.27	Vol2.18M
Open11.82	D1 Closing12.19	Amplitude5.93%
Mkt Cap1.60B	Tradable Cap1.24B	Total Shares138.00M
T/O25.20M	T/O Rate2.04%	Tradable Shares107.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CMPS","market":"US","secType":"STK","nameCN":"COMPASS Pathways plc","latestPrice":11.57,"timestamp":1793390400000,"preClose":12.19,"halted":0,"volume":2180332,"hourTrading":{"tag":"盘前","latestPrice":11.98,"preClose":11.57,"latestTime":"04:10 EST","volume":42,"amount":503.658792,"timestamp":1793610635196,"change":0.41,"changeRate":0.035436,"amplitude":0.009507},"delay":0,"changeRate":-0.050861361771944155,"floatShares":107000000,"shares":138000000,"eps":-3.611848,"marketStatus":"Pre-Mkt","change":-0.62,"latestTime":"11-02 04:25:58 EST","open":11.822,"high":11.9932,"low":11.27,"amount":25200545.436836,"amplitude":0.059327,"askPrice":12.7,"askSize":40,"bidPrice":10.7,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-3.611848,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1793629800000},"marketStatusCode":1,"adr":0,"adrRate":1,"listingDate":1600401600000,"exchange":"NASDAQ","adjPreClose":11.57,"preHourTrading":{"tag":"盘前","latestPrice":11.98,"preClose":11.57,"latestTime":"04:10 EST","volume":42,"amount":503.658792,"timestamp":1793610635196,"change":0.41,"changeRate":0.035436,"amplitude":0.009507},"postHourTrading":{"tag":"盘后","latestPrice":11.63,"preClose":11.57,"latestTime":"19:59 EDT","volume":51476,"amount":595506.2755,"timestamp":1793404799343,"change":0.06,"changeRate":0.005186,"amplitude":0.011236},"volumeRatio":1.4052087409751643,"impliedVol":0.83,"impliedVolPercentile":0.388},"requestUrl":"/m/hq/s/CMPS/wiki","defaultTab":"wiki","newsList":[{"id":"2679210809","title":"Compass Pathways PLC Expected to Post a Loss of 45 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2679210809","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679210809?lang=en_us&edition=fundamental","pubTime":"2026-10-30 21:56","pubTimestamp":1793368572,"startTime":"0","endTime":"0","summary":"Compass Pathways PLC <CMPS.OQ> expected to post a loss of45cents a share - Earnings PreviewCompass Pathways PLCCMPS.OQCMPS.Ois expected to  show no change in quarterly revenue when it reports  results","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261030:nL5N46G1Q3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMPS","BK4139","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678646343","title":"Compass Pathways Presents Comp360 Psilocybin Research at NEI Fall Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2678646343","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678646343?lang=en_us&edition=fundamental","pubTime":"2026-10-28 18:31","pubTimestamp":1793183465,"startTime":"0","endTime":"0","summary":"Compass Pathways Presents COMP360 Psilocybin Research at NEI Fall CongressCompass Pathways will attend the Neuroscience Education Institute Fall Congress in Colorado Springs, Colorado, Nov. 5-8, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261028:nNDL1wRlsl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSIL","BK4139","CMPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678814173","title":"Compass Pathways to Report Third-Quarter Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2678814173","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678814173?lang=en_us&edition=fundamental","pubTime":"2026-10-27 18:30","pubTimestamp":1793097027,"startTime":"0","endTime":"0","summary":"Compass Pathways to Report Third-Quarter Financial ResultsCompass Pathways will release third-quarter results for the period ended Sept. 30, 2026, on Nov. 3, 2026.A business update is also scheduled for Nov. 3, with a management conference call at 8 a.m. ET .Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Compass Pathways plc published the original content used to generate this news brief via Business Wire  on October 27, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261027:nNDL9MVRqG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMPS","BK4139","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678717807","title":"Compass Pathways to Announce Third Quarter 2026 Financial Results on November 3, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2678717807","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678717807?lang=en_us&edition=fundamental","pubTime":"2026-10-27 18:30","pubTimestamp":1793097000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261027:nTUA9VHCBC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PSIL","BK4139","CMPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676656689","title":"COMPASS Pathways (CMPS) Reports Positive Phase 3 Data, Is The Premium Still Justified?","url":"https://stock-news.laohu8.com/highlight/detail?id=2676656689","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676656689?lang=en_us&edition=fundamental","pubTime":"2026-10-20 11:30","pubTimestamp":1792467024,"startTime":"0","endTime":"0","summary":"COMPASS Pathways (CMPS) has moved back into focus after reporting positive Phase 3 trial data for its lead psilocybin therapy, COMP360. This milestone has sharpened attention on the stock’s premium valuation.\nOver the past month, COMPASS Pathways has given back some of its earlier gains, with a 30 day share price return down 26.86%, even though the year to date share price return sits at 69.62% and the 3 year total shareholder return is up 100.54%. This suggests that recent excitement around...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cmps/compass-pathways/news/compass-pathways-cmps-reports-positive-phase-3-data-is-the-p","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cmps/compass-pathways/news/compass-pathways-cmps-reports-positive-phase-3-data-is-the-p","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","CMPS","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124625844","title":"Morgan Stanley Initiates Eight Biotech Names, Rating Seven Overweight","url":"https://stock-news.laohu8.com/highlight/detail?id=1124625844","media":"Analyst Calls","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124625844?lang=en_us&edition=fundamental","pubTime":"2026-10-20 10:11","pubTimestamp":1792462284,"startTime":"0","endTime":"0","summary":"","market":"other","thumbnail":"https://static.tigerbbs.com/96e20408c3934de428b82e38a778cc26","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/96e20408c3934de428b82e38a778cc26"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Morgan Stanley Initiates Eight Biotech Names, Rating Seven Overweight","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMPS","TRVI","PTCT","BLTE","AVLN","RGNX"],"isVideo":true,"video":{"duration":320,"video_url":"https://news-video-sg.skytigris.cn/videos/remotion/3928/render_3928_1792461663591.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3928.webp","audio_url":"https://news-video-sg.skytigris.cn/videos/remotion/3928/tts/voiceover_2510d0822d39909bff1e8933.mp3","isAI":true},"gpt_icon":0},{"id":"2676576938","title":"Phase 3 Trial Success Might Change The Case For COMPASS Pathways Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2676576938","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676576938?lang=en_us&edition=fundamental","pubTime":"2026-10-19 06:27","pubTimestamp":1792362455,"startTime":"0","endTime":"0","summary":"COMPASS Pathways reported positive Phase 3 results for its lead therapy, COMP360, in treatment resistant depression, reinforcing clinical progress toward potential regulatory filings.\nThe strong readout for COMP360 highlights how a single late stage asset underpins COMPASS Pathways' potential future revenue and capital requirements.\nThis article examines how COMPASS Pathways' investment narrative could change in response to the positive Phase 3 data for COMP360.\n\nCompare COMPASS Pathways'...","market":"us","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cmps/compass-pathways/news/phase-3-trial-success-might-change-the-case-for-compass-path","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cmps/compass-pathways/news/phase-3-trial-success-might-change-the-case-for-compass-path","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PSIL","CMPS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675897553","title":"Cathie Wood’s ARK Investment buys 284K shares of Compass Pathways today","url":"https://stock-news.laohu8.com/highlight/detail?id=2675897553","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675897553?lang=en_us&edition=fundamental","pubTime":"2026-10-13 09:15","pubTimestamp":1791854115,"startTime":"0","endTime":"0","summary":"21:10 EDT Cathie Wood’s ARK Investment buys 284K shares of Compass Pathways (CMPS) today Published first on TheFly – the ultimate source for real-t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cathie-woods-ark-investment-buys-284k-shares-of-compass-pathways-today-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cathie-woods-ark-investment-buys-284k-shares-of-compass-pathways-today-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CMPS","BK4585","SARK","ARKQ","ARKG","BK4544","ARKF","ARKW","PSIL","ARKX","BK4588","ARKK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672517716","title":"Compass Pathways Announces New Employee Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672517716","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672517716?lang=en_us&edition=fundamental","pubTime":"2026-10-02 18:30","pubTimestamp":1790937000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nTUA2VGXHP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CMPS","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671203212","title":"Compass Pathways Names Kelley Boucher Chief People Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2671203212","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671203212?lang=en_us&edition=fundamental","pubTime":"2026-09-30 18:30","pubTimestamp":1790764240,"startTime":"0","endTime":"0","summary":"Compass Pathways names Kelley Boucher chief people officerCompass Pathways appointed Kelley Boucher as chief people officer, effective today.Role includes oversight of people strategy as the company s","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nNDL7zWWlC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00B19Z9Z06.USD","PSIL","ALNY","LU0109394709.USD","PBE","BIIB","LU0114720955.EUR","BK4532","BMED","LU0234570918.USD","BK4585","CMPS","BK4139","LU0882574055.USD","BK4533","BK4548","LU0889565916.HKD","IE00B894F039.SGD","IE00B19Z9P08.USD","LU0320765992.SGD","GNMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669816703","title":"H.C. Wainwright Sticks to Its Buy Rating for COMPASS Pathways (CMPS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669816703","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669816703?lang=en_us&edition=fundamental","pubTime":"2026-09-22 01:56","pubTimestamp":1790013377,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Patrick Trucchio maintained a Buy rating on COMPASS Pathways today and set a price target of $65.00. Trucchio covers the He...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-sticks-to-its-buy-rating-for-compass-pathways-cmps-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-sticks-to-its-buy-rating-for-compass-pathways-cmps-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CMPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667460228","title":"Compass Pathways Joins TD Cowen Novel Mechanisms in Neuropsychiatry Summit Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2667460228","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667460228?lang=en_us&edition=fundamental","pubTime":"2026-09-16 18:30","pubTimestamp":1789554631,"startTime":"0","endTime":"0","summary":"Compass Pathways joins TD Cowen Novel Mechanisms in Neuropsychiatry Summit fireside chatCompass Pathways will attend TD Cowen’s 6th Annual Novel Mechanisms in Neuropsychiatry Summit on Sept. 23, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nNDL1sXVMd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSIL","BK4139","CMPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667862533","title":"As Trump Backs Psychedelics Research, FDA Weighs Safety and Access Standards","url":"https://stock-news.laohu8.com/highlight/detail?id=2667862533","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667862533?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:16","pubTimestamp":1789485372,"startTime":"0","endTime":"0","summary":"The strongest evidence for use of the drugs so far has come from trials in patients with severe depression or post-traumatic stress disorder who have not responded to existing treatments.Early-stage trials are also testing psychedelic drugs for substance abuse disorders, borderline personality disorder, obsessive-compulsive disorders, anxiety, self-harm behavior, chronic Lyme disease and fibromyalgia.HOW DO PSYCHEDELIC TREATMENTS WORK?Psychedelic treatments work primarily by activating proteins on the surface of nerve cells that regulate the brain's ability to reorganize, form new connections, and repair damaged circuits. Unlike traditional psychiatric drugs that may be taken at home on a daily basis, these treatments are usually administered by medical personnel in a limited number of sessions to supplement intensive psychotherapy.WHAT PSYCHEDELIC DRUGS ARE CURRENTLY AUTHORIZED FOR USE?In the U.S. and Europe, the leading candidate for authorization is psilocybin, the active ingredient","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL1N4570B8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BBT3K403.USD","LU2456880835.USD","IE0001KFT4U8.USD","LU1914381329.SGD","LU1066051225.USD","LU0426412945.USD","LU0053666078.USD","LU0122379950.USD","SG9999001176.USD","IE00B19Z3581.USD","LU1145028129.USD","MEDX","LU2756315318.SGD","IE0002270589.USD","IE00B7SZLL34.SGD","LU0820561909.HKD","LU1551013425.SGD","LU0820561818.USD","LU1244550221.USD","LU1674673428.USD","LU0795875169.SGD","SG9999002224.SGD","LU1291159041.SGD","IE00B42XCP33.USD","LU0345770993.USD","LU1894683264.USD","IE00B3T34201.USD","LU1989771016.USD","IE00BJJMRZ35.SGD","LU2756315664.SGD","LU2750360997.AUD","FHLC","LU1061106388.HKD","LU1059921491.USD","LU1066051811.HKD","IE00BZ1G4Q59.USD","LU0203345920.USD","IE00BVYPNW00.USD","LU1228905540.USD","LU2430703178.SGD","LU0072461881.USD","LU1228905037.USD","LU1267930813.SGD","IE000SO60NU8.SGD","LU2403377893.USD","BK4592","IE000WAW04H5.SGD","IE00B4R5TH58.HKD","SG9999001176.SGD","LU1074936037.SGD","LU1221951046.USD","IE000M9KFDE8.USD","LU2505996681.GBP","LU1066053197.SGD","LU2750360641.GBP","LU0234572021.USD","LU2471134523.USD","LU0203347892.USD","LU0289961442.SGD","LU1929549753.HKD","LU0683600562.USD","LU0511384066.AUD","LU0210536198.USD","IE00BDGV0183.EUR","VHT","LU1718418525.SGD","LU2112291526.USD","LU0545562505.USD","CMPS","LU1496350502.SGD","BK4533","LU0234570918.USD","BK4588","IE0034235303.USD","FTXH","IE00B1BXHZ80.USD","LU1778281490.HKD","LU1057294990.SGD","LU0058720904.USD","LU2236285917.USD","IE0000B7K699.USD","LU0795875086.SGD","LU2487616109.SGD","LU2133065610.SGD","LU1244550577.SGD","IE0009355771.USD","TRUH","BK4504","BK4139","LU1196500208.SGD","LU2471134952.CNY","IE00BFTCPJ56.SGD","LU1674673691.USD","LU1280957306.USD","LU0289739699.SGD","LU0472753341.HKD","LU1032466523.USD","BK4581","IE00BLSP4239.USD","LU1221951129.SGD","SG9999002232.USD","LU2896262040.SGD","XLV","LU0345769128.USD","LU0345769631.USD","LU0640476718.USD","LU2129689431.USD","BK4568","IE00B3PB1722.GBP","LU0426417589.USD","LU2023250330.USD","IE000MB6IJN5.SGD","IE00BFXG1179.USD","PSIL","LU0114720955.EUR","LU0912757837.SGD","LU0289739343.SGD","LU0689472784.USD","LU1023059063.AUD","IE00BGHQF631.EUR","IE00BVYPNV92.GBP","LU2213496289.HKD","SG9999001440.SGD","LU1261432733.SGD","LU0210528500.USD","LU1244550494.USD","LU1162221912.USD","LU1066051498.USD","BK4007","LU0882574055.USD","LU0432979614.USD","IE00BJT1NW94.SGD","BK4585","LU0985320562.USD","LU0098860793.USD","LU2089984988.USD","LU2430703095.HKD","JNJ","LU1551013342.USD","SG9999013999.USD","LU0162691827.USD","LU1894683348.USD","LU1043141123.HKD","LU1032955483.USD","IE0002141913.USD","LU1506573853.SGD","PBM","LU2430703251.USD","LU0964807845.USD","IE00BLSP4452.SGD","LU1430594728.SGD","LU0787776722.HKD","LU2129689514.USD","LU0466842654.USD","LU0124676726.USD","LU0889566641.SGD","JDOC","LU0792757196.USD","LU0345770308.USD","LU1585245621.USD","LU2468319806.SGD","LU2602419157.SGD","SGXZ80539844.SGD","LU2347655156.SGD","LU0057025933.USD","IE00BKVL7J92.USD","LU0820562030.AUD","GDOC","IHE","LU0320765646.SGD","LU2471134879.HKD","LU1935042991.SGD","IE00B19Z3B42.SGD","IE00BN8TJ469.HKD","SGXZ57979304.SGD","LU2592432038.USD","LU1043141396.HKD","LU2471134796.USD","LU2505996509.AUD","LU2417539215.USD","LU0994945656.USD","IXJ","LU1121112475.USD","LU1629891620.HKD","IYH","BK4532","IE000F7OJYX1.SGD","BK4559","LU2129689605.HKD","LU0943347566.SGD","PJP","LU1732800096.USD","IE000BZT7R73.USD","LU1983299246.USD","LU0069063385.USD","BMED","BK4534","BK4550","IE00B2B36J28.USD","RXL","LU1732799900.SGD","IE00BSNM7G36.USD","LU0070217475.USD","LU0689626769.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667462036","title":"Compass Pathways Launches ‘Change the Tune in Trd’ in the U.S. to Advance Hcp Understanding of Treatment-Resistant Depression at Psych Congress 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2667462036","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667462036?lang=en_us&edition=fundamental","pubTime":"2026-09-15 18:30","pubTimestamp":1789468200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nTUA90S5ST:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CMPS","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667693327","title":"Experts Urge FDA to Set Clear Safety and Access Standards for Psychedelic Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2667693327","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667693327?lang=en_us&edition=fundamental","pubTime":"2026-09-15 03:30","pubTimestamp":1789414223,"startTime":"0","endTime":"0","summary":"UPDATE 2-Experts urge FDA to set clear safety and access standards for psychedelic drugsSept 14 (Reuters)-Doctors, veterans, pharmacists and therapists on Monday urged the U.S. Food and Drug Administr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nL1N4560R3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GHRS","BK4539","CMPS","BK4139","PSIL","DFTX","ATAI","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667667454","title":"FDA to Hold Public Hearing on Psychedelic Drugs as Trump-Driven Push Gathers Pace","url":"https://stock-news.laohu8.com/highlight/detail?id=2667667454","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667667454?lang=en_us&edition=fundamental","pubTime":"2026-09-15 00:20","pubTimestamp":1789402802,"startTime":"0","endTime":"0","summary":"FDA to hold public hearing on psychedelic drugs as Trump-driven push gathers paceSept 14 (Reuters)-The U.S. Food and Drug Administration will hold a public hearing on Monday to gather feedback on the ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nL4N4531CQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","PSIL","BK4139","BK4539","ATAI","CMPS","GHRS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666257102","title":"Strata Mental Health Solutions awarded training grant by Compass Pathways","url":"https://stock-news.laohu8.com/highlight/detail?id=2666257102","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666257102?lang=en_us&edition=fundamental","pubTime":"2026-09-12 04:15","pubTimestamp":1789157710,"startTime":"0","endTime":"0","summary":"Strata Mental Health Solutions announced it has been awarded one of the five U.S. HCP training grants awarded by Compass Pathways (CMPS) to develop...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/strata-mental-health-solutions-awarded-training-grant-by-compass-pathways-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/strata-mental-health-solutions-awarded-training-grant-by-compass-pathways-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PSIL","CMPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666956780","title":"Compass Pathways Announces U.S. Grant Program Recipients for the Development of Post-Approval Comp360 Provider Training","url":"https://stock-news.laohu8.com/highlight/detail?id=2666956780","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666956780?lang=en_us&edition=fundamental","pubTime":"2026-09-10 18:35","pubTimestamp":1789036500,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nTUA8YJNLY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CMPS","PSIL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666562043","title":"Compass Pathways Management Attends Investor Conference Fireside Chats in New York Week of Sept. 14","url":"https://stock-news.laohu8.com/highlight/detail?id=2666562043","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666562043?lang=en_us&edition=fundamental","pubTime":"2026-09-10 18:30","pubTimestamp":1789036255,"startTime":"0","endTime":"0","summary":"Compass Pathways management attends investor conference fireside chats in New York week of Sept. 14Compass Pathways management to join investor conferences in New York during the week of Sept. 14.Fire","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL86MRVT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSIL","BK4139","CMPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666532640","title":"U.S. Stocks on the MOVE-Apple, Omnicom, Jersey Mike's Subs","url":"https://stock-news.laohu8.com/highlight/detail?id=2666532640","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666532640?lang=en_us&edition=fundamental","pubTime":"2026-09-10 01:54","pubTimestamp":1788976474,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Apple, Omnicom, Jersey Mike's SubsSeptember 9  (Reuters)-The main U.S. stock indexes fell on Wednesday as oil prices soared past $100 a barrel and Treasury yields rose, pu","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nL6N4510Q4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TH","TYRA","VDE","CI","EVMN","BKNG","CMPS","OMC","IRT","IXC","SIG","GAMR","CASY","SUNB","DOW","UGI","ABNB","COP","OXY","META","LYFT","BKKT","XOM","SFD","EAF","CGNT","IXN","TBBK","JILL","OGIG","TRUC","XOMX","AAPL","IRD","UNH","TTAN","LFST","CHYM","CVX","KFY","METU","DIG","BKV","SAIL","ASO","SMMT","WLK","CHWY","VTRS","INGM"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.compasspathways.com","stockEarnings":[{"period":"1week","weight":0.0349},{"period":"1month","weight":-0.0699},{"period":"3month","weight":0.0194},{"period":"6month","weight":0.2841},{"period":"1year","weight":0.8365},{"period":"ytd","weight":0.6768}],"compareEarnings":[{"period":"1week","weight":-0.0056},{"period":"1month","weight":-0.0091},{"period":"3month","weight":0.0116},{"period":"6month","weight":0.0487},{"period":"1year","weight":0.1116},{"period":"ytd","weight":0.1082}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.053854},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.067409},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.124725},{"month":4,"riseRate":0.5,"avgChangeRate":0.092687},{"month":5,"riseRate":0.5,"avgChangeRate":0.037097},{"month":6,"riseRate":0.666667,"avgChangeRate":-0.001204},{"month":7,"riseRate":0.666667,"avgChangeRate":0.185901},{"month":8,"riseRate":0.5,"avgChangeRate":0.026891},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.097517},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.017872},{"month":11,"riseRate":0.333333,"avgChangeRate":0.034765},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.01163}],"exchange":"NASDAQ","name":"COMPASS Pathways plc","nameEN":"COMPASS Pathways plc","securityTypeName":"DR","adrRate":"1:1"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.1","shortVersion":"4.52.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"COMPASS Pathways plc(CMPS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest COMPASS Pathways plc(CMPS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"COMPASS Pathways plc,CMPS,COMPASS Pathways plc股票,COMPASS Pathways plc股票老虎,COMPASS Pathways plc股票老虎国际,COMPASS Pathways plc行情,COMPASS Pathways plc股票行情,COMPASS Pathways plc股价,COMPASS Pathways plc股市,COMPASS Pathways plc股票价格,COMPASS Pathways plc股票交易,COMPASS Pathways plc股票购买,COMPASS Pathways plc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"COMPASS Pathways plc(CMPS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest COMPASS Pathways plc(CMPS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}